• Home
  • Privacy Policy
  • Terms & Conditions
  • Thank you
Profit News Report
No Result
View All Result
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
No Result
View All Result
Profit News Report
No Result
View All Result
Home Investing

Spotify stock is inexpensive after Q4 earnings: find out more

by
February 11, 2026
in Investing
0
Spotify stock is inexpensive after Q4 earnings: find out more
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Spotify Technology (NYSE: SPOT) is pushing meaningfully higher in premarket on Tuesday after the audio streaming giant posted a blockbuster Q4 and issued surprisingly positive outlook for the current quarter.

While the massive headline beat and user growth sure are contributing to it, investors are cheering SPOT primarily for the big boost to efficiency.

For months, they’ve been concerned that it may fail to evolve into a high-margin business.

Today’s release, however, suggested otherwise — helping Spotify stock soar nearly 14% this morning.

What’s driving Spotify stock higher after Q4 earnings?

In Q4, Spotify’s gross margin hit a record 33.1%, which is really the “Holy Grail” for its investors.

Why? Because it confirms that the company’s pivot into audiobooks and “higher-margin” podcast advertising is bearing fruit.

The NYSE-listed company also added 38 million new users in the fourth quarter, the largest quarterly increase in its history, underscoring that even as a mature media services player, it continues to expand its user base and has yet to reach a clear growth ceiling.

Following the post-earnings surge, SPOT stock looks headed to test a “key resistance” coinciding with its 20-day moving average (MA) at the $492 level.

A “decisive break” above that price could accelerate upward momentum in the near-term.

SPOT shares have pushed past last year’s overhang

At €4.43 per share, Spotify topped Street estimates by an exciting “55%”, as social charges related to pesky Swedish payroll taxes that weighed on its stock last year, remained lower-than-expected in Q4.

In fact, the firm’s operating income printed at an all-time high of €701 million, indicating its price hikes in key markets like the US, Estonia, and Latvia are also sitting rather well with users.

Investors ran into Spotify shares this morning because they loved the Q1 guidance as well, calling for “759” million users and continued profitability.

This suggests leadership transition from Daniel Ek to new co-chief executives, Gustav Soderstrom and Alex Norstrom, is going much smoother than the bears anticipated.

All in all, SPOT crashed in the second half of 2025 as markets questioned if it could ever make real money – and the company’s quarterly release on February 10th answered with a resounding “yes”.

Spotify Technology is currently trading at a discount

Long-term investors should consider buying SPOT shares into the post-earnings strength because at a price-to-sales (P/S) multiple of about “4.37” only, they are much cheaper than rival Netflix at roughly “7.7”.

Plus, the audio streaming and media services company is still down some 40% versus its 52-week high as well.

Spotify Technology generated €834 million in free cash flow in the fourth quarter alone, bringing its full-year total to nearly €3 billion, of which it used more than €350 million to repurchase its stock.

This commitment to returning capital to investors via share repurchase makes investing in this firm even more exciting for those interested in holding it for years.

The post Spotify stock is inexpensive after Q4 earnings: find out more appeared first on Invezz

Previous Post

From Eddie Bauer to Saks Global: what’s ailing US retailers?

Next Post

US stocks open higher on Tuesday: Dow Jones jumps 200 points to hit new ATH

Next Post
US stocks open higher on Tuesday: Dow Jones jumps 200 points to hit new ATH

US stocks open higher on Tuesday: Dow Jones jumps 200 points to hit new ATH

  • Trending
  • Comments
  • Latest
Trump’s Fed Criticism Sparks Investor Concerns

Trump’s Fed Criticism Sparks Investor Concerns

April 22, 2025
A look back at Biden’s Remarkable 50-year career in politics

A look back at Biden’s Remarkable 50-year career in politics

March 20, 2025
Fed’s Stagflation Warning Impacts Crypto Markets

Fed’s Stagflation Warning Impacts Crypto Markets

April 21, 2025
Spire Healthcare shares surge 20% after confirming talks with buyout firms

Spire Healthcare shares surge 20% after confirming talks with buyout firms

January 27, 2026
FDA refuses to review Moderna’s mRNA flu vaccine application

FDA refuses to review Moderna’s mRNA flu vaccine application

0
Nvidia Stock Tumbles on Earnings Anticipation and AI Rivalry

Nvidia Stock Tumbles on Earnings Anticipation and AI Rivalry

0
The dollar index continues to pull back to a new low

The dollar index continues to pull back to a new low

0
BNGO Stock: BioNano Genomics Analysis and Forecast

BNGO Stock: BioNano Genomics Analysis and Forecast

0
FDA refuses to review Moderna’s mRNA flu vaccine application

FDA refuses to review Moderna’s mRNA flu vaccine application

February 11, 2026
US futures steady as retail sales, jobs and CPI data take center stage

US futures steady as retail sales, jobs and CPI data take center stage

February 11, 2026
Coca-Cola stock slumps as Q4 revenue misses estimates

Coca-Cola stock slumps as Q4 revenue misses estimates

February 11, 2026
CVS Health beats expectations as turnaround strategy gains traction

CVS Health beats expectations as turnaround strategy gains traction

February 11, 2026

Recent News

FDA refuses to review Moderna’s mRNA flu vaccine application

FDA refuses to review Moderna’s mRNA flu vaccine application

February 11, 2026
US futures steady as retail sales, jobs and CPI data take center stage

US futures steady as retail sales, jobs and CPI data take center stage

February 11, 2026
Coca-Cola stock slumps as Q4 revenue misses estimates

Coca-Cola stock slumps as Q4 revenue misses estimates

February 11, 2026
CVS Health beats expectations as turnaround strategy gains traction

CVS Health beats expectations as turnaround strategy gains traction

February 11, 2026
  • Privacy Policy
  • Terms & Conditions
  • Privacy Policy
  • Terms & Conditions

Disclaimer: Profitnewsreport.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Copyright © 2025 Profitnewsreport.com

No Result
View All Result
  • Home
  • Privacy Policy
  • Terms & Conditions
  • Thank you

Disclaimer: Profitnewsreport.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Copyright © 2025 Profitnewsreport.com